Evaluation of Dupilumab in Chinese Adult Patients With Moderate to Severe Atopic Dermatitis
Condition: Atopic Dermatitis Interventions: Drug: dupilumab SAR231893; Drug: placebo; Drug: Emollient (moisturizer) Sponsors: Sanofi; Regeneron Pharmaceuticals Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials